Vinorelbine and Gemcitabine as Second- or Third-Line Therapy for Malignant Pleural Mesothelioma

OBJECTIVES: Pemetrexed-cisplatin is the only FDA-approved regimen for malignant pleural mesothelioma (MPM), and the impact on survival is modest. No drugs have been shown to improve survival as second-line therapy, yet vinorelbine and gemcitabine are prescribed based on the results of small phase II...

Full description

Saved in:
Bibliographic Details
Published in:Lung Cancer
Main Authors: Zauderer, Marjorie G., Kass, Samantha L., Woo, Kaitlin, Sima, Camelia S., Ginsberg, Michelle S., Krug, Lee M.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4343315/
https://ncbi.nlm.nih.gov/pubmed/24690410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2014.03.006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items